Effect of Sirolimus on Left Ventricular Hypertrophy in Kidney Transplant Recipients: A 1-Year Nonrandomized Controlled Trial

Conversion from CNI to SRL therapy may regress LVH in RTRs regardless of BP changes, mainly by decreasing left ventricular wall thickness, thus suggesting nonhemodynamic-effect mechanisms of SRL on left ventricular mass.